Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody engineering

A J George1

  • 1Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital.

Endeavour
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Paul Ehrlich pioneered antibody therapy to target toxic molecules. Genetic engineering now enables antibody manipulation for treating malignant diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vulvar and vestibulovaginal hemangiosarcoma in a cow: morphological and histopathological observations.

Iranian journal of veterinary research·2023
Same author

Comparative assessment of faecal diagnostics for detection and predictive modelling of endemic Fasciola hepatica infection in sheep and cattle on Australian farms.

Veterinary parasitology·2021
Same author

Effectiveness of self-portraits used over personal protective equipment during the COVID-19 pandemic among patients and healthcare workers.

The British journal of surgery·2021
Same author

Comparative assessment of faecal diagnostics for detection and predictive modelling of endemic <i>Fasciola hepatica</i> infection in sheep and cattle on Australian farms.

Veterinary parasitology: X·2020
Same author

Comparison between a fixed-dose contrast protocol and a weight-based contrast dosing protocol in abdominal CT.

Clinical radiology·2016
Same author

Micro-CT scouting for transmission electron microscopy of human tissue specimens.

Journal of microscopy·2016
Same journal

Don't Let Elon Musk Convince You that AI is the Bad Guy: A Film Review of Good Luck, Have Fun, Don't Die, Directed by Gore Verbinski. Briarcliff Entertainment, 2026.

Endeavour·2026
Same journal

WITHDRAWN: Feathered architects: Collecting histories of anthropogenic material in birds' nests.

Endeavour·2026
Same journal

Editorial.

Endeavour·2026
Same journal

"We shall do all we can to help you": The Society for Protection of Science and Learning's interwar attempt to aid refugee orthopedists and oncologists.

Endeavour·2026
Same journal

The Welwitsch Study Set: A collection ecology.

Endeavour·2026
Same journal

Giant bones and giants' bodies: Collection ecologies, 1500-1700.

Endeavour·2026
See all related articles

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Paul Ehrlich's early 20th-century concept of targeted molecular therapy using antibodies.
  • The historical significance of antibody-based treatments for diseases.

Purpose of the Study:

  • To explore the evolution of antibody-based therapies from historical concepts to modern applications.
  • To highlight the impact of genetic engineering on antibody development for cancer treatment.

Main Methods:

  • Review of historical scientific contributions in antibody therapy.
  • Analysis of recent advancements in genetic engineering techniques for antibody modification.

Main Results:

  • Demonstration of the feasibility of isolating and manipulating antibody genes.

Related Experiment Videos

  • Creation of novel antibody-based molecules with therapeutic potential.

    • Conclusions:

    • Genetic engineering has significantly expanded the therapeutic possibilities of antibody-based treatments.
    • Targeted antibody therapies represent a promising avenue for managing malignant diseases.